Page last updated: 2024-09-03

vadimezan and Adenocarcinoma, Alveolar

vadimezan has been researched along with Adenocarcinoma, Alveolar in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albelda, SM; Cheng, G; Fridlender, ZG; Jassar, A; Kapoor, V; Levy, L; Mishalian, I; Singhal, S; Sun, J; Wang, LC	1

Other Studies

1 other study(ies) available for vadimezan and Adenocarcinoma, Alveolar

Article	Year
Using macrophage activation to augment immunotherapy of established tumours. British journal of cancer, 2013, Apr-02, Volume: 108, Issue:6 Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Female; Immunotherapy; Lung Neoplasms; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myeloid Cells; Neutrophils; Tumor Microenvironment; Xanthones	2013

Article

Year

Using macrophage activation to augment immunotherapy of established tumours.

British journal of cancer, 2013, Apr-02, Volume: 108, Issue:6

Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Female; Immunotherapy; Lung Neoplasms; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myeloid Cells; Neutrophils; Tumor Microenvironment; Xanthones

2013